Abstract
Introduction and hypothesis
There is significant variability in technique for cystodistension and an international discrepancy in the role in its treatment of bladder pain syndrome (BPS). The authors evaluate the evidence base for the use of cystodistension for BPS with particular reference to patient-related outcomes.
Methods
In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement, a prospective search and evaluation protocol was prepared and registered with the PROSPERO database (ID CRD42017053710). A review of the literature was performed using the search terms cystodistension and hydrodistension of the bladder using the PubMed database on 6 October 2016.
Results
A total of 59 papers were reviewed, but only 17 studies contained original data available for analysis from 1975 to 2016. Ten studies evaluated the outcome of cystodistension in a single arm design or used cystodistension as the control for evaluating adjunctive treatments. Seven studies evaluated cystodistension in combination with other agents or therapies. The best symptomatic responses reported a subjective improvement in 56% of men with moderate to severe prostatitis and 57% in patients with “inflammatory cystitis” respectively. There were no studies that employed a validated outcome measure, neither a questionnaire nor an analogue scale, to assess the effect of cystodistension alone.
Conclusions
Cystodistension is increasingly popular, despite a weak evidence base by current standards. The quality of available evidence falls below the level that would be expected of a new intervention. This review highlights the need for cystodistension to be further investigated with randomised control trials.
Similar content being viewed by others
References
Doggweiler R, Whitmore KE, Meijlink JM, et al. A standard for terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the International Continence Society. Neurourol Urodyn. 2017;36(4):984–1008. doi:10.1002/nau.23072.
European Association of Urology. Chronic pelvic pain. In: European Association Urology Guideline. 2016. https://uroweb.org/guideline/chronic-pelvic-pain/#1. Accessed February 2017.
Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333.
American Urology Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. In: American Urology Association Guideline. 2014. https://www.auanet.org/common/pdf/education/clinical-guidance/IC-Bladder-Pain-Syndrome-Revised.pdf. Accessed 5 January 2016.
Bumpus HJ. Interstitial cystitis: its treatment by over-distention of the bladder. Med Clin North Am. 1930;13:1495–8.
Helmstein K. Treatment of bladder carcinoma by a hydrostatic pressure technique. Report on 43 cases. Br J Urol. 1972;44(4):434–50.
Dunn M, Smith JC, Ardran GM. Prolonged bladder distension as a treatment of urgency and urge incontinence of urine. Br J Urol. 1974;46(6):645–52.
Arieff AJ, Tigay EL, Pyzik SW. Acute hypertension induced by urinary bladder distension. Headache and its correlates in quadriplegic patients. Arch Neurol. 1962;6:248–56.
Jørgensen L, Mortensen SO, Colstrup H, Andersen JT. Bladder distension in the management of detrusor instability. Scand J Urol Nephrol. 1985;19(2):101–4.
Mahendru AA, Al-Taher H. Cystodistension: certainly no standards and possibly no benefits—survey of UK practice. Int Urogynecol J. 2010;21(2):135–9.
Turner KJ, Stewart LH. How do you stretch a bladder? A survey of UK practice, a literature review, and a recommendation of a standard approach. Neurourol Urodyn. 2005;24(1):74–6.
Homma Y, Ueda T, Tomoe H, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009;16(7):597–615.
Peters KM, Killinger KA, Mounayer MH, Boura JA. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology. 2011;78(2):301–8.
Niimi A, Nomiya A, Yamada Y, et al. Hydrodistension with or without fulguration of Hunner lesions for interstitial cystitis: long-term outcomes and prognostic predictors. Neurourol Urodyn. 2015;35(8):965–9.
Tomoe H. In what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective? Transl Androl Urol. 2015;4(6):600–4.
Manning J, Dwyer P, Rosamilia A. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum a (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2014;25(5):593–9.
Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention? Neurourol Urodyn. 2005;24(7):638–42.
Berger RE, Miller JE, Rothman I, Krieger JN, Muller CH. Bladder petechiae after cystoscopy and hydrodistension in men diagnosed with prostate pain. J Urol. 1998;159(1):83–5.
Hsieh CH, Chang WC, Huang MC, et al. Hydrodistention plus bladder training versus hydrodistention for the treatment of interstitial cystitis. Taiwan J Obstet Gynecol. 2012;51(4):591–5.
Glemain P, Rivière C, Lenormand L, Karam G, Bouchot O, Buzelin JM. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur Urol. 2002;41(1):79–84.
Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int J Urol. 2003;10(9):463–8.
Erickson DR, Kunselman AR, Bentley CM, et al. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007;177(2):556–60.
Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494–9.
Hanley RS, Stoffel JT, Zagha RM, Mourtzinos A, Bresette JF. Multimodal therapy for painful bladder syndrome / interstitial cystitis: pilot study combining behavioral, pharmacologic, and endoscopic therapies. Int Braz J Urol. 2009;35(4):467–74.
Aihara K, Hirayama A, Tanaka N, Fujimoto K, Yoshida K, Hirao Y. Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol. 2009;16(12):947–52.
Lentz GM, Bavendam T, Stenchever MA, Miller JL, Smalldridge J. Hormonal manipulation in women with chronic, cyclic irritable bladder symptoms and pelvic pain. Am J Obstet Gynecol. 2002;186(6):1268–71.
Leppilahti M, Hellström P, Tammela TL. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology. 2002;60(1):46–51.
McCahy PJ, Styles RA. Prolonged bladder distension: experience in the treatment of detrusor overactivity and interstitial cystitis. Eur Urol. 1995;28(4):325–7.
Lloyd SN, Lloyd SM, Rogers K, Deane RF, Kirk D, Kyle KF. Is there still a place for prolonged bladder distension? Br J Urol. 1992;70(4):382–6.
Dunn M, Ramsden PD, Roberts JB, Smith JC, Smith PJ. Interstitial cystitis, treated by prolonged bladder distension. Br J Urol. 1977;49(7):641–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Ethics committee/institutional review board
Ethics approval is not required for this article, as no study on humans was conducted.
Rights and permissions
About this article
Cite this article
Olson, L.E., Dyer, J.E., Haq, A. et al. A systematic review of the literature on cystodistension in bladder pain syndrome. Int Urogynecol J 29, 251–257 (2018). https://doi.org/10.1007/s00192-017-3355-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-017-3355-y